{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:16:13Z","timestamp":1777493773771,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2024\/03\/31811"],"award-info":[{"award-number":["PSAU\/2024\/03\/31811"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jpet.2025.103592","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T15:11:27Z","timestamp":1745593887000},"page":"103592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bioactive phytoconstituent millettone as a potential inhibitor of catechol O-methyltransferase: Implications for neuroprotective therapy in Parkinson's disease"],"prefix":"10.1016","volume":"392","author":[{"given":"Mohammad","family":"Khalid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7061-9111","authenticated-orcid":false,"given":"Mohammed H.","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6728-8614","authenticated-orcid":false,"given":"Ahmed I.","family":"Foudah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103592_bib1","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.1080\/07391102.2023.2228912","article-title":"Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach","volume":"42","author":"Alam","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jpet.2025.103592_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fmolb.2019.00041","article-title":"Structural analysis and conformational dynamics of STN1 gene mutations involved in coat plus syndrome","volume":"6","author":"Amir","year":"2019","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.jpet.2025.103592_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/acs.jnatprod.5b00947","article-title":"Feeling nature\u2019s PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS)","volume":"79","author":"Baell","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.jpet.2025.103592_bib4","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/jp9536920","article-title":"Principal component analysis and long time protein dynamics","volume":"100","author":"Balsera","year":"1996","journal-title":"J Phys Chem"},{"key":"10.1016\/j.jpet.2025.103592_bib5","first-page":"10","article-title":"Protein data bank","volume":"233","author":"Bank","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1016\/j.jpet.2025.103592_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3923\/ijb.2008.406.420","article-title":"Traditional uses of the African Millettia species (Fabaceae)","volume":"4","author":"Banzouzi","year":"2008","journal-title":"Int J Bot"},{"key":"10.1016\/j.jpet.2025.103592_bib7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1021\/mp0700209","article-title":"The rule of five revisited: applying log D in place of log P in drug-likeness filters","volume":"4","author":"Bhal","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1016\/j.jpet.2025.103592_bib8","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1063\/1.437567","article-title":"Molecular dynamics of polymeric systems","volume":"70","author":"Bishop","year":"1979","journal-title":"J Chem Phys"},{"key":"10.1016\/j.jpet.2025.103592_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-9752-7_7","article-title":"Hydrogen bonds in protein-ligand complexes","volume":"2053","author":"Bitencourt-Ferreira","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jpet.2025.103592_bib10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s12010-012-9725-5","article-title":"In silico analyses of COMT, an important signaling cascade of dopaminergic neurotransmission pathway, for drug development of Parkinson\u2019s disease","volume":"167","author":"Chakraborty","year":"2012","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.jpet.2025.103592_bib11","doi-asserted-by":"crossref","first-page":"34752","DOI":"10.1074\/jbc.M111.262790","article-title":"Orientation and cellular distribution of membrane-bound catechol-O-methyltransferase in cortical neurons: implications for drug development","volume":"286","author":"Chen","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpet.2025.103592_bib12","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1021\/jm5019093","article-title":"PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS","volume":"58","author":"Dahlin","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2025.103592_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103592_bib14","first-page":"6716","article-title":"Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms","volume":"61","author":"Dawling","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpet.2025.103592_bib15","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newsl Protein Crystallogr"},{"key":"10.1016\/j.jpet.2025.103592_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11101-022-09845-w","article-title":"Millettia isoflavonoids: a comprehensive review of structural diversity, extraction, isolation, and pharmacological properties","volume":"22","author":"Desta","year":"2023","journal-title":"Phytochem Rev"},{"key":"10.1016\/j.jpet.2025.103592_bib17","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1107\/S1399004714012917","article-title":"Mapping the conformational space accessible to catechol-O-methyltransferase","volume":"70","author":"Ehler","year":"2014","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.jpet.2025.103592_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/prot.10001","article-title":"Evaluation of a fast implicit solvent model for molecular dynamics simulations","volume":"46","author":"Ferrara","year":"2002","journal-title":"Proteins"},{"key":"10.1016\/j.jpet.2025.103592_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","article-title":"Prediction of the biological activity spectra of organic compounds using the PASS online web resource","volume":"50","author":"Filimonov","year":"2014","journal-title":"Chem Heterocycl Compd"},{"key":"10.1016\/j.jpet.2025.103592_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0076-6879(03)74020-8","article-title":"Modeller: generation and refinement of homology-based protein structure models","volume":"374","author":"Fiser","year":"2003","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.jpet.2025.103592_bib21","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1038\/npp.2008.82","article-title":"Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism","volume":"33","author":"Giakoumaki","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpet.2025.103592_bib22","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1002\/elps.1150181505","article-title":"SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling","volume":"18","author":"Guex","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jpet.2025.103592_bib23","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2174\/156652411798062386","article-title":"Diverse facets of COMT: from a plausible predictive marker to a potential drug target for schizophrenia","volume":"11","author":"Gupta","year":"2011","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jpet.2025.103592_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jmgm.2017.03.002","article-title":"Molecular dynamics simulation studies of novel \u03b2-lactamase inhibitor","volume":"74","author":"Haq","year":"2017","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.jpet.2025.103592_bib25","series-title":"Protein Folding Dynamics and Stability: Experimental and Computational Methods","first-page":"221","article-title":"Molecular dynamics simulation to study thermal unfolding in proteins","author":"Hassan","year":"2023"},{"key":"10.1016\/j.jpet.2025.103592_bib26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/1574893615666191219094216","article-title":"Relevance of molecular docking studies in drug designing","volume":"15","author":"Jakhar","year":"2020","journal-title":"Curr Bioinform"},{"key":"10.1016\/j.jpet.2025.103592_bib27","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2165\/00003495-200059060-00004","article-title":"Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease","volume":"59","author":"Kaakkola","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.jpet.2025.103592_bib28","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/brain\/awz084","article-title":"Cell-specific overexpression of COMT in dopaminergic neurons of Parkinson's disease","volume":"142","author":"Kuzumaki","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.jpet.2025.103592_bib29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bioinformatics\/16.8.747","article-title":"PASS: prediction of activity spectra for biologically active substances","volume":"16","author":"Lagunin","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jpet.2025.103592_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.jpet.2025.103592_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1021\/ct9005745","article-title":"Relation between free energy landscapes of proteins and dynamics","volume":"6","author":"Maisuradze","year":"2010","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.jpet.2025.103592_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0031-6997(24)01423-6","article-title":"Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors","volume":"51","author":"M\u00e4nnist\u00f6","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jpet.2025.103592_bib33","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.3390\/molecules24244589","article-title":"Identification of high-affinity inhibitors of cyclin-dependent kinase 2 towards anticancer therapy","volume":"24","author":"Mohammad","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103592_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2024.100458","article-title":"Identifying potential inhibitors of phosphatidylinositol 4,5-bisphosphate 3-kinase: molecular dynamic insights into the interaction and inhibitory mechanism","volume":"8","author":"Mohammad","year":"2024","journal-title":"Chem Phys Impact"},{"key":"10.1016\/j.jpet.2025.103592_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa279","article-title":"InstaDock: a single-click graphical user interface for molecular docking-based virtual high-throughput screening","volume":"22","author":"Mohammad","year":"2021","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.jpet.2025.103592_bib36","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3390\/molecules25040823","article-title":"Virtual screening approach to identify high-affinity inhibitors of serum and glucocorticoid-regulated kinase 1 among bioactive natural products: combined molecular docking and simulation studies","volume":"25","author":"Mohammad","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103592_bib37","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1038\/s41598-018-22631-z","article-title":"IMPPAT: a curated database of Indian medicinal plants, phytochemistry and therapeutics","volume":"8","author":"Mohanraj","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103592_bib38","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2174\/1568026618666181025114157","article-title":"Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships","volume":"18","author":"Naqvi","year":"2018","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jpet.2025.103592_bib39","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/cmdc.200600155","article-title":"Prediction of ADMET properties","volume":"1","author":"Norinder","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jpet.2025.103592_bib40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jmgm.2009.01.006","article-title":"Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case","volume":"27","author":"Papaleo","year":"2009","journal-title":"J Mol Graph Model"},{"key":"10.1016\/j.jpet.2025.103592_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12870-023-04702-0","article-title":"Genome-wide characterization of COMT family and regulatory role of CsCOMT19 in melatonin synthesis in Camellia sinensis","volume":"24","author":"Pham","year":"2024","journal-title":"BMC Plant Biol"},{"key":"10.1016\/j.jpet.2025.103592_bib42","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.bbapap.2010.04.008","article-title":"Computational approaches for protein function prediction: a combined strategy from multiple sequence alignment to molecular docking-based virtual screening","volume":"1804","author":"Pierri","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jpet.2025.103592_bib43","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.jpet.2025.103592_bib44","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.bmcl.2018.03.057","article-title":"Synthesis, biological evaluation and molecular docking study of 1-amino-2-aroylnaphthalenes against prostate cancer","volume":"28","author":"Rai","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jpet.2025.103592_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jmb.2008.04.040","article-title":"Crystal structures of human 108V and 108M catechol O-methyltransferase","volume":"380","author":"Rutherford","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jpet.2025.103592_bib46","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","article-title":"How molecular size impacts RMSD applications in molecular dynamics simulations","volume":"13","author":"Sargsyan","year":"2017","journal-title":"J Chem Theory Comput"},{"key":"10.1016\/j.jpet.2025.103592_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/07391102.2024.2308764","article-title":"Targeting PDE4A for therapeutic potential: exploiting drug repurposing approach through virtual screening and molecular dynamics","author":"Shamsi","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.jpet.2025.103592_bib48","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ijbiomac.2020.01.134","article-title":"Probing the interaction of rivastigmine tartrate, an important Alzheimer\u2019s drug, with serum albumin: attempting treatment of Alzheimer\u2019s disease","volume":"148","author":"Shamsi","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.jpet.2025.103592_bib49","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3390\/biom9090495","article-title":"Unraveling binding mechanism of Alzheimer\u2019s drug rivastigmine tartrate with human transferrin: molecular docking and multi-spectroscopic approach towards neurodegenerative diseases","volume":"9","author":"Shamsi","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpet.2025.103592_bib50","first-page":"420","article-title":"Discovery studio","author":"Studio","year":"2008","journal-title":"Accelrys"},{"key":"10.1016\/j.jpet.2025.103592_bib51","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jpet.2025.103592_bib52","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"key":"10.1016\/j.jpet.2025.103592_bib53","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/368354a0","article-title":"Crystal structure of catechol O-methyltransferase","volume":"368","author":"Vidgren","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.jpet.2025.103592_bib54","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/acsomega.3c00156","article-title":"IMPPAT 2.0: an enhanced and expanded phytochemical atlas of Indian medicinal plants","volume":"8","author":"Vivek-Ananth","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpet.2025.103592_bib55","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.3390\/molecules27103060","article-title":"Bioactive phytoconstituents as potent inhibitors of tyrosine-protein kinase yes (YES1): implications in anticancer therapeutics","volume":"27","author":"Yang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpet.2025.103592_bib56","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/s41598-017-02365-0","article-title":"CarcinoPred-EL: novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jpet.2025.103592_bib57","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1021\/acs.jcim.9b00552","article-title":"Validation of the generalized force fields GAFF, CGenFF, OPLS-AA, and PRODRGFF by testing against experimental osmotic coefficient data for small drug-like molecules","volume":"59","author":"Zhu","year":"2019","journal-title":"J Chem Inf Model"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525398058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T10:18:16Z","timestamp":1751019496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525398058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0022356525398058"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103592","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioactive phytoconstituent millettone as a potential inhibitor of catechol O-methyltransferase: Implications for neuroprotective therapy in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103592"}}